Glucose Fresenius

Glucose Fresenius is an intravenous solution that contains the active ingredient glucose monohydrate. It is supplied as a sterile liquid for parenteral administration, with the specific concentration not disclosed in the product label. Classified as an excipient/solvent and a nutritional supplement, this EU‑marketed product is prescribed for medical use to provide an immediate source of glucose when delivered intravenously.

Glucose Fresenius is indicated for several clinical situations where rapid glucose supplementation is required. It is commonly employed in the following contexts:

- Treatment of hypoglycemia to quickly raise blood glucose levels. - Fluid and electrolyte replacement in patients unable to tolerate oral intake. - Nutritional support for patients undergoing surgery or critical illness. - As a carrier solution for intravenous drug admixtures. - Management of metabolic disorders requiring controlled glucose infusion.

Glucose Fresenius may be associated with a range of adverse reactions, most of which are related to the rapid infusion of glucose or the osmolarity of the solution.

Common: - Hyperglycemia or elevated blood glucose levels. - Local irritation at the infusion site. - Mild nausea or vomiting. - Headache or dizziness. - Transient electrolyte imbalance.

Serious: - Severe hyperglycemia leading to osmotic diuresis. - Allergic reaction or anaphylaxis. - Fluid overload causing pulmonary edema. - Severe electrolyte disturbances (e.g., hyponatremia).

When using Glucose Fresenius, healthcare professionals should consider several safety measures to minimize risks. Important precautions include:

- Assessing baseline blood glucose and electrolyte status before infusion. - Adjusting infusion rate in patients with renal or cardiac insufficiency. - Monitoring for signs of fluid overload, especially in elderly or critically ill patients. - Using aseptic technique to prevent catheter‑related infections. - Avoiding use in patients with known hypersensitivity to glucose solutions. - Documenting infusion details and patient response in the medical record.

Glucose Fresenius can interact with other medications or clinical conditions, influencing its safety and efficacy. Interactions to be aware of are:

Avoid: - Concurrent administration of high‑dose insulin without appropriate glucose monitoring. - Use with other hypertonic solutions that may exacerbate fluid overload.

Use with caution: - Co‑administration with diuretics that affect electrolyte balance. - Patients receiving corticosteroids, which may increase blood glucose levels. - Concurrent use of beta‑blockers that can mask hypoglycemia symptoms. - Situations where the patient is receiving total parenteral nutrition containing additional glucose.